Progenity
precision medicine disruptive platform and pipeline progenity | Progenity
Company
Deck Type
IPO
Deck date
June 2020
Slide
17 of 24
Related slides by other companies
LumiraDx
Investor Presentation
March 2023
platform simplifies scales down and integrates principles used in lab systems | LumiraDx
BenevolentAI
Investor Day
September 2022
our precision medicine approaches are applied to multiple stages of our pipeline and can support activities precision medicine enabled target indication mapping additional indications a target or drug approved or in development through the cation of additional disease indications address additional unmet need the value of a target or drug identifying key patient cohorts and responders for drugs clinical development increase probability of success improve outcomes for patients cation of patient cohorts responders trial design patient outcomes for each indication | BenevolentAI
Exscientia
Investor Presentation
June 2022
patient first is a learning process | Exscientia
Exscientia
Investor Presentation
October 2023
patient first is a learning process in ses | Exscientia
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights